PhillipAErwinMDPhD, FACC

Cardiology • Aurora, CO

Interventional Cardiology

Director of Structural Interventional Cardiology, VA Eastern Colorado Health Care System

Join to view full profile

Dr. Erwin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Erwin's full profile

Already have an account?

Office
VA Eastern Colorado Health Care System
1700 N Wheeling St
Aurora, CO 80045
Phone+1 303-399-8020
Is this information wrong?

Summary

I am a board certified interventional cardiologist specializing in complex coronary disease, high risk coronary intervention (e.g., use of Impella, ECMO, and alternative access) and transcatheter aortic valve replacement (TAVR).

Education & Training

Cleveland Clinic FoundationFellowship, Interventional Cardiology, 2013 - 2015
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2010 - 2013
Massachusetts General HospitalResidency, Internal Medicine, 2007 - 2010
Harvard Medical SchoolClass of 2007, MD, PhD

Certifications & Licensure

FL State Medical License 2015 - 2025
NY State Medical License 2010 - 2025
CO State Medical License 2020 - 2025
OH State Medical License 2013 - 2017
SC State Medical License 2015 - 2015
MA State Medical License 2009 - 2010
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Publications & Presentations

PubMed

48 citations
Epidemiology of fibromuscular dysplasia: A review of the literature
Daniel Shivapour, Phillip A. Erwin, Esther S.H. Kim> ;Vascular Medicine. 2016 Apr 11
3 citations
Visceral fibromuscular dysplasia in a patient with chronic abdominal pain
Phillip A. Erwin, Joseph-Vincent V. Blas, Sagar S. Gandhi, Maria Romero, Bruce H. Gray> ;Vascular Medicine. 2016 Apr 1
3 citations
Restoration of Renal Allograft Function via Reduced-Contrast Percutaneous Revascularization of Transplant Renal Artery Stenosis
Phillip A. Erwin, Sachin S. Goel, Surafel Gebreselassie, Mehdi H. Shishehbor> ;Texas Heart Institute Journal. 2015 Feb 1
Contemporary management of femoral popliteal revascularization
Phillip A. Erwin, Mehdi H. Shishehbor> ;Interventional Cardiology Clinics. 2014 Oct 1
3 citations
Evaluation of the patient who presents with critical limb ischemia: diagnosis, prognosis, and medical management
Ian Del Conde, Phillip A. Erwin> ;Techniques in Vascular and Interventional Radiology. 2014 Sep 1
Renal artery stenting: indications, techniques, and devices.
Erwin, P. A.,Shishehbor, M. H.> ;Minerva Cardioangiol. 2013 Apr
Angiographic complications and post-PCI myocardial enzyme elevation: Brave new world revisited†
George Dangas, Phillip Erwin> ;Catheterization and Cardiovascular Interventions. 2010 Dec 1
84 citations
Subcellular Targeting and Differential S-Nitrosylation of Endothelial Nitric-oxide Synthase
Phillip A. Erwin, Douglas A. Mitchell, Juliano L. Sartoretto, Michael A. Marletta, Thomas Michel> ;The Journal of Biological Chemistry. 2006 Jan 6
154 citations
Receptor-regulated Dynamic S-Nitrosylation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
Phillip A. Erwin, Alison J. Lin, David E. Golan, Thomas Michel> ;The Journal of Biological Chemistry. 2005 May 20
56 citations
S-Nitrosation and regulation of inducible nitric oxide synthase.
Douglas A. Mitchell, Phillip A. Erwin, Thomas Michel, Michael A. Marletta> ;Biochemistry. 2005 Mar 4
159 citations
VEGF induces S1P1 receptors in endothelial cells: Implications for cross-talk between sphingolipid and growth factor receptors.
Junsuke Igarashi, Phillip A. Erwin, Ana Paula Dantas, Hongjie Chen, Thomas Michel> ;Proceedings of the National Academy of Sciences of the United States of America. 2003 Sep 16
Join now to see all

Press Mentions

Cardiac and Kidney Health: Innovative Approach to Address BothSeptember 4th, 2020
Miami Cardiac & Vascular Institute’s Heart Valve Replacement Program (TAVR) Expands to South Miami HospitalFebruary 17th, 2020